Skip to main content
Equibles

MetLife Investment Management, LLC

Position in OCGN — Ocugen, Inc.

CIK 1529735 Whippany, NJ
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$308,239
+$276,633 QoQ
Shares Held
201,464
+350.0% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 147 holders
Holding Since
Jun 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. OCGN ranks #159 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in OCGN

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $308,239 201,464
2025-03-31 $31,606 44,769
2024-12-31 $137,217 170,456
2024-09-30 $88,791 89,508
2024-06-30 $101,728 65,631
2023-03-31 $99,140 116,226
2022-12-31 $92,199 70,923
2022-09-30 $200,306 112,532
2022-06-30 $255,447 112,532
2022-03-31 $222,769 67,506
2021-12-31 $300,222 65,983
2021-09-30 $408,513 56,896
2021-06-30 $544,329 67,787